Biomerica, Inc.

NasdaqCM:BMRA Rapporto sulle azioni

Cap. di mercato: US$6.0m

Biomerica Gestione

Gestione criteri di controllo 3/4

Biomerica Il CEO è Zack Irani, nominato in Apr1997, e ha un mandato di 27.58 anni. la retribuzione annua totale è $ 360.10K, composta da 41.7% di stipendio e 58.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 6.07% delle azioni della società, per un valore di $ 362.30K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.1 anni e 7.5 anni.

Informazioni chiave

Zack Irani

Amministratore delegato

US$360.1k

Compenso totale

Percentuale dello stipendio del CEO41.7%
Mandato del CEO27.6yrs
Proprietà del CEO6.1%
Durata media del management3.1yrs
Durata media del Consiglio di amministrazione7.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?

Dec 20
Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching Biomerica's (NASDAQ:BMRA) Cash Burn Situation

Aug 31
Here's Why We're Watching Biomerica's (NASDAQ:BMRA) Cash Burn Situation

We're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Rate

Mar 04
We're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Rate

Amazon starts selling Biomerica's Aware Breast Self Exam device, EZ Detect test

Sep 29

Biomerica: One To Watch Closely For The Future, But From The Sidelines For Now

Sep 09

Biomerica reports FY results

Aug 29

Biomerica stock jumps after Walmart to begin selling co's Aware Breast Self Exam device

Jul 14

Most Shareholders Will Probably Find That The CEO Compensation For Biomerica, Inc. (NASDAQ:BMRA) Is Reasonable

Dec 03
Most Shareholders Will Probably Find That The CEO Compensation For Biomerica, Inc. (NASDAQ:BMRA) Is Reasonable

Biomerica (NASDAQ:BMRA) Is In A Good Position To Deliver On Growth Plans

Dec 02
Biomerica (NASDAQ:BMRA) Is In A Good Position To Deliver On Growth Plans

Is Biomerica Stock A Buy Or Sell After Q4 Earnings? Catalysts To Watch Into 2022

Sep 15

Biomerica (BMRA) Investor Presentation - Slideshow

Jun 14

Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

Jun 13
Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

Biomerica, Inc.'s (NASDAQ:BMRA) Profit Outlook

Apr 04
Biomerica, Inc.'s (NASDAQ:BMRA) Profit Outlook

Should You Review Recent Insider Transactions At Biomerica, Inc. (NASDAQ:BMRA)?

Mar 08
Should You Review Recent Insider Transactions At Biomerica, Inc. (NASDAQ:BMRA)?

Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

Feb 10
Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

The Biomerica (NASDAQ:BMRA) Share Price Has Soared 405%, Delighting Many Shareholders

Jan 15
The Biomerica (NASDAQ:BMRA) Share Price Has Soared 405%, Delighting Many Shareholders

Biomerica soars as its COVID-19 antigen test wins European nod

Jan 12

When Will Biomerica, Inc. (NASDAQ:BMRA) Become Profitable?

Dec 20
When Will Biomerica, Inc. (NASDAQ:BMRA) Become Profitable?

Biomerica clinical trial for IBS nears enrollment completion

Dec 09

How Much Does Biomerica's (NASDAQ:BMRA) CEO Make?

Nov 23
How Much Does Biomerica's (NASDAQ:BMRA) CEO Make?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Zack Irani rispetto agli utili di Biomerica?
DataCompenso totaleStipendioGuadagni aziendali
Aug 31 2024n/an/a

-US$6m

May 31 2024US$360kUS$150k

-US$6m

Feb 29 2024n/an/a

-US$6m

Nov 30 2023n/an/a

-US$6m

Aug 31 2023n/an/a

-US$6m

May 31 2023US$141kUS$141k

-US$7m

Feb 28 2023n/an/a

-US$7m

Nov 30 2022n/an/a

-US$6m

Aug 31 2022n/an/a

-US$5m

May 31 2022US$491kUS$135k

-US$5m

Feb 28 2022n/an/a

-US$4m

Nov 30 2021n/an/a

-US$7m

Aug 31 2021n/an/a

-US$7m

May 31 2021US$488kUS$137k

-US$7m

Feb 28 2021n/an/a

-US$6m

Nov 30 2020n/an/a

-US$5m

Aug 31 2020n/an/a

-US$4m

May 31 2020US$330kUS$137k

-US$2m

Feb 29 2020n/an/a

-US$3m

Nov 30 2019n/an/a

-US$2m

Aug 31 2019n/an/a

-US$2m

May 31 2019US$329kUS$137k

-US$2m

Feb 28 2019n/an/a

-US$2m

Nov 30 2018n/an/a

-US$2m

Aug 31 2018n/an/a

-US$2m

May 31 2018US$295kUS$137k

-US$1m

Compensazione vs Mercato: La retribuzione totale di Zack ($USD 360.10K ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 653.78K ).

Compensazione vs guadagni: La retribuzione di Zack è aumentata nonostante l'azienda non sia redditizia.


AMMINISTRATORE DELEGATO

Zack Irani (58 yo)

27.6yrs

Mandato

US$360,103

Compensazione

Mr. Zackary S. Irani, also known as Zack, has been Chief Executive Officer of Biomerica Inc. since April 29, 1997 and is its Director and served as its President. He was Chairman of the Board at Biomerica...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Zackary Irani
CEO & Director27.6yrsUS$360.10k6.07%
$ 362.3k
Allen Barbieri
Executive Vice-Chairman of the Board & Corporate Secretary25.1yrsUS$243.98k0.47%
$ 27.8k
Gary Lu
Principal Accounting Officer & CFO1.7yrsUS$385.64k0%
$ 0
Lucy Liu
Director of Manufacturing & Technical Operationsno dataNessun datoNessun dato
Robert Carlson
Chief Commercial Officer2.3yrsNessun datoNessun dato

3.1yrs

Durata media

58yo

Età media

Gestione esperta: Il team dirigenziale di BMRA è considerato esperto (durata media dell'incarico 3.1 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Zackary Irani
CEO & Directorno dataUS$360.10k6.07%
$ 362.3k
Allen Barbieri
Executive Vice-Chairman of the Board & Corporate Secretary25.1yrsUS$243.98k0.47%
$ 27.8k
Edward Barnholt
Chairman of Strategic Advisory Board8.3yrsNessun datoNessun dato
Harry Leider
Member of Strategic Advisory Board6.6yrsNessun datoNessun dato
Douglas Drossman
Member of the Scientific Advisory Boardno dataNessun datoNessun dato
William Chey
Member of the Scientific Advisory Boardno dataNessun datoNessun dato
Jane Emerson
Independent Director17.6yrsUS$137.71k0.42%
$ 25.2k
Anthony Lembo
Member of Scientific Advisory Board8.3yrsNessun datoNessun dato
David Moatazedi
Independent Director1.9yrsUS$157.82k0%
$ 0
Catherine Coste
Independent Director4.2yrsUS$145.21k0.26%
$ 15.5k
Brooks Cash
Chairman of Colorectal Screening Scientific Advisory Board3yrsNessun datoNessun dato
William Whitehead
Member of the Scientific Advisory Boardno dataNessun datoNessun dato

7.5yrs

Durata media

66yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di BMRA sono considerati esperti (durata media dell'incarico 7.5 anni).